Skip to main content
SpringerLink
Log in

kardiologie und Angiologie

  • Chapter
Medizin im Brennpunkt

  • 45 Accesses

Zusammenfassung

AV-Knoten-Reentry-Tachykardien (AV-junktionale Reentry- Tachykardien, AVNRT) gehören neben den Tachykardien unter Einbeziehung akzessorischer Leitungsbahnen zu den häufigsten Ursachen paroxysmaler supraventrikulärer Tachykardien [6]. Während in früheren Jahren das Konzept der aus schließlich intranodal gelegenen Kreisbahn bestanden hatte, konnte in der letzten Zeit durch experimentelle und intra operative Mappinguntersuchungen sowie durch Ergebnisse der Hochfrequenzstrom-Katheterablation gezeigt werden, daß den AVNRT ein komplexes pathophysiologisches Substrat unter Einbeziehung des AV-Knotens und des perinodalen Vörhofmyokards zugrunde liegt [2,4,5,7,8,12].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 44.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 59.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

2.1 Pathophysiologie der AV-Knoten-Reentry-Tachykardie

  1. Anderson RH, Becker AE, Brechenmacher C, Davies MJ, Rossi L (1975) The human atrioventricular junctional area: A morphological study of the A-V node and bündle. Eur J Cardiol 3:11–25

    PubMed  CAS  Google Scholar 

  2. Cox JL, Holman WL, Cain MEe (1987) Cryosurgical treatment of atrioventricular node reentrant tachycardia. Circulation 76:1329–1336

    Article  PubMed  CAS  Google Scholar 

  3. Denes P, Wu D, Dhingra RC, et al. (1973) Demonstration of dual A- V nodal pathways in patients with paroxysmal supraventricular tachycardia. Circulation 48:549–555

    PubMed  CAS  Google Scholar 

  4. Haissaguerre M, Gaita F, Fischer B, et al. (1992) Elimination of atrioventricular nodal reentrant tachycardia using discrete slow potentials to guide application of radiofrequency energy. Circulation 85: 2162–2175

    PubMed  CAS  Google Scholar 

  5. Jackman WM, Beckman KJ, McClelland JH, et al. (1992) Treatment of supraventricular tachycardia due to atrioventricular nodal reentry by radiofrequency catheter ablation of slow-pathway conduction. N Engl J Med 327:313–318

    Article  PubMed  CAS  Google Scholar 

  6. Josephson ME (1993) Supraventricular tachycardias. In: Josephson ME (ed) Clinical cardiac electrophysiology. Lea & Febiger, Philadelphia, London, p 181–275

    Google Scholar 

  7. Kottkamp H, Hindricks G, Willems S et al (1995) An anatomically and electrogram-guided stepwise approach for effective and safe catheter ablation of the fast pathway for elimination of atrioventricular node reentrant tachycardia. J Am Coll Cardiol 25:974–981

    Article  PubMed  CAS  Google Scholar 

  8. McGuire MA, Bourke JP, Robotin MC, Johnson DC, Meldrum-Han- na W, Nunn GR, Uther JB, Ross DL (1993) High resolution mapping of Koch’s triangle using sixty electrodes in humans with atrioventricular junctional (AV nodal) reentrant tachycardia. Circulation 88: 2315–2328

    PubMed  CAS  Google Scholar 

  9. Mines GR (1913) On dynamic equilibrium of the heart. J Physiol (London) 46:349–382

    CAS  Google Scholar 

  10. Moe GK, Preston JB, Burlington HJ (1956) Physiologic evidence for a dual A-V transmission system. Circ Res 4:357–375

    PubMed  CAS  Google Scholar 

  11. Rosen KM, Mehta A, Miller RA (1974) Demonstration of dual AV nodal pathways in man. Am J Cardiol 33: 291–294

    Article  PubMed  CAS  Google Scholar 

  12. Ross DL, Johnnson DC, Denniss AR, Cooper MJ, Richards DA, Uther JB (1985) Curative surgery for atrioventricular junctional (AV nodal) reentrant tachycardia. J Am Coll Cardiol 6:1383–1392

    Article  PubMed  CAS  Google Scholar 

  13. Scherf D, Shookhoff C (1926) Experimentelle Untersuchungen über die „Umkehr-Extrasystole“(reciprocating beat). Wien Arch Inn Med 12: 501–529

    Google Scholar 

  14. Sung R, Harvey LW, Saksena S, Juma Z (1981) Sequence of retrograde atrial activation in patients with dual atrioventricular pathways. Circulation 64:1059–1067

    Article  PubMed  CAS  Google Scholar 

2.2 Thrombolyse beim „non-Q-Wave”-lnfarkt?

  1. Ardissino D, Barberis P, de Servi S (1990) Recombinant tissuetype plasminogen activator followed by heparin compared with heparin alone for refractory unstable angina pectoris. Am J Cardiol 66: 910–914

    Article  PubMed  CAS  Google Scholar 

  2. Bär FW, Verheugt FW, Col J, Materne P, Monassier JP, Geslin PG, Metzger J, Raxnaud P, Foucault J, de Zwaan C, Vermeer F (1992) Thrombolysis in patients with unstable angina improves the angiographic but not the clinical outcome. Results of UNASEM, a multicenter, randomized placebo-controlled, clinical trial with anistreplase. Circulation 86:131–137

    PubMed  Google Scholar 

  3. Giri S, Waters DD (1966) Pathophysiology and initial management of the acute coronary syndromes. Curr Opin Cardiol 11:351–360

    Article  Google Scholar 

  4. Osborne JA, Stone PH (1994) Recent advances in the understanding and mangement of stable and unstable angina pectoris and asymptomatic myocardial ischemia. Curr Opin Cardiol 9: 448–456

    Article  PubMed  CAS  Google Scholar 

  5. Schreiber TL, Macina G, McNulty A (1989) Urokinase plus heparin versus aspirin in unstable angina and non-Q-wave-myocardial infarction. Am J Cardiol 64: 840–844

    Article  PubMed  CAS  Google Scholar 

  6. Stone PH, Thompson B, Anderson V, Kronenberg MW, Gibson RS, Rogers WJ, Diver DJ, Theroux P, Warnica W, Nasmith JB, Keils C, Kleinman N, McCabe CH, Schactman M, Knatterud GL, Braun wald E (1996) Influence of race, sex, and age on management of unstable angina and non-Q-wave myocardial infarction. JAMA 275:1104–1112

    Article  PubMed  CAS  Google Scholar 

  7. TIMI-IIA Investigators (1993) Early effects of tissue-type plasminogen activator to conventional therapy on the culprit coronary lesion in patients presenting with ischemic cardiac pain at rest: results of the thrombolysis in myocardial ischemia (TIMI- IIIA). Circulation 87:38–52

    Google Scholar 

  8. TIMI-IIIB Investigators (1994) Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non-Q-wave myocardial infarction. Circulation 89:1545–1556

    Google Scholar 

  9. Woo KS, White HD (1994) Thrombolytic therapy in acute myocardial infarction. Curr Opin Cardiol 9: 471–482

    Article  PubMed  CAS  Google Scholar 

2.3 Systemische Lyse bei intrakardialen Thromben?

  1. Abassade P, lung B, Boudouy PY, Vuong PN, Valleteau de Moulliac M (1991) Bilateral renal embolism during thrombolysis with tissue plasminogen activator in a patient with a left ventricular thrombus. Arch Mal Coeur Vaiss 84: 583–585

    PubMed  CAS  Google Scholar 

  2. Arvan S (1983) Left ventricular mural thrombi secondary to acute myocardial infarction: predisposing factors and embolic phenomenon. J Clin Ultrasound 11: 467–473

    Article  PubMed  CAS  Google Scholar 

  3. ASPECT Research Group (1994) Effect of long term oral anti coagulant treatment on mortality and cardiovascular morbidity after myocardial infarction. Lancet 343: 499–503

    Google Scholar 

  4. Bhatnagar SK, AI Yusuf AR (1983) Left ventricular thrombi after myocardial infarction. Postgrad Med J 59: 495–499

    Article  PubMed  CAS  Google Scholar 

  5. Bhatnagar SK, AI Yusuf AR (1991) Effects of intravenous recombinant tissue type plasminogen activator therapy on the incidence and associations of left ventricular thrombus in patients with a first acute Q wave anterior myocardial infarction. Am Heart J122:1251–1256

    Article  Google Scholar 

  6. Dantzig van JM, Delemarre BJ, Bot H, Visser CA (1996) Left ventricular thrombus in acute myocardial infarction. Eur Heart J 17:1640–1645

    PubMed  Google Scholar 

  7. Domenicucci S, Chiarella F, Bellotti P, Lupi G, Scarsi G, Vecchio C (1990) Early appearance of left ventricular thrombi after anterior myocardial infarction: a marker of higher in-hospital mortality in patients not treated with antithrombotic drugs. Eur Heart J 11:51–58

    PubMed  CAS  Google Scholar 

  8. Eigler N, Maurer G, Shah PK (1984) Effect of early systemic thrombolytic therapy on left ventricular thrombus formation in acute myocardial infarction. Am J Cardiol 54: 261–263

    Article  PubMed  CAS  Google Scholar 

  9. Funke-Küpper AJ, Verheugt FWA, Peels CH, Galema TW, Roos JP (1989) Left ventricular thrombus incidence and behavior studied by serial two dimensional echocardiography in acute anterior myocardial infarction: left ventricular wall motion, systemic embolism and oral anticoagulation. J Am Coll Cardiol 13:1514–1520

    Article  Google Scholar 

  10. Haugland JM, Asinger RW, Mikell FL, Elsperger J, Morrison Hodges (1984) Embolic potential of left ventricular thrombi detected by two dimensional echocardiography. Circulation 70: 588–598

    Article  PubMed  CAS  Google Scholar 

  11. Heik SCW, Kupper W, Hamm C (1994) Efficacy of high dose intravenous heparin for treatment of left ventricular thrombi with high embolic risk. J Am Coll Cardiol 24:1305–1309

    Article  PubMed  CAS  Google Scholar 

  12. Held AC, Gore JM, Paraskos J (1988) Impact of thrombolytic therapy on left ventricular mural thrombi in acute myocardial infarction. Am J Cardiol 62:310–311

    Article  PubMed  CAS  Google Scholar 

  13. Johannessen KA, Nordrehaug JE, Von der Lippe G, Vollset SE (1988) Risk factors for embolisation in patients with left ventricular thrombi and acute myocardial infarction. Br Heart J 60:104–110

    Article  PubMed  CAS  Google Scholar 

  14. Jordan RA, Miller RD, Edwards JE, Parker RL (1952) Thromboembolism in acute and in healed myocardial infarction. Intracardiac mural thrombosis. Circulation 6:1–6

    PubMed  CAS  Google Scholar 

  15. Jugdutt BI, Sivaram CA (1989) Prospective two-dimensional echocardiographic evaluation of left ventricular thrombus and ambolism after acute myocardial infarction. J Am Coll Cardiol 13: 554–564

    Article  PubMed  CAS  Google Scholar 

  16. Keren A, Goldberg S, Gottlieb S (1990) Natural history of left ventricular thrombi: their appearance and resolution in the posthospitalization period of acute myocardial infarction. J Am Coll Cardiol 15: 790–800

    Article  PubMed  CAS  Google Scholar 

  17. Lupi G, Domenicucci S, Chiarella F, Bellotti P, Vecchio C (1989) Influence of thrombolytic treatment followed by full dose anticoagulation on the frequency of left ventricular thrombi in acute myocardial infarction. Am J Cardiol 64: 588–590

    Article  PubMed  CAS  Google Scholar 

  18. Natarajan D, Hotchandani RK, Nigam PD (1988) Reduced incidence of left ventricular thrombi with intravenous streptokinase in acute myocardial infarction: prospective evaluation by cross sectional echocardiography. Int J Cardiol 20: 201–207

    Article  PubMed  CAS  Google Scholar 

  19. Nihoyannopoulos P, Smith GC, Maseri A, Foale RA (1989) The natural history of left ventricular thrombus in myocardial infarction: a rationale in support of masterly inactivity. J Am Coll Cardiol 14: 903–911

    Article  PubMed  CAS  Google Scholar 

  20. Smith P, Arnesen H, Holme I (1990) The effect of warfarin on mortality and reinfarction after myocardial infarction. N Engl J Med 154: 2649–2657

    Google Scholar 

  21. Spirito P, Bellotti P, Chiarella F, Domenicucci S, Sementa A, Vecchio C (1985) Prognostic significance and natural history of left ventricular thrombi in patients with acute anterior myocardial infarction: a two dimensional echocardiographic study. Circulation 72: 774–780

    Article  PubMed  CAS  Google Scholar 

  22. Stratton JR, Resnick AD (1987) Increased embolic risk in patients with left ventricular thrombi. Circulation 75:1004–1011

    Article  PubMed  CAS  Google Scholar 

  23. Visser CA, Kan G, Meltzer RS, Dunning AJ, Roelandt J (1985) Embolic potential of left ventricular thrombus after myocardial infarction: a two dimensional echocardiographic study of 119 patients. J Am Coll Cardiol 1276–1280

    Google Scholar 

  24. Visser CA, Kan G, Meltzer RS, Lie Kl, Durrer D (1984) Long-term follow-up of left ventricular thrombus after acute myocardial infarction: a two-dimensional echocardiographic study in 96 patients. Chest 86: 532–536

    Article  PubMed  CAS  Google Scholar 

2.4 Kardiomyopathie durch Antidepressiva

  1. Acosta D, Ramos K (1984) Cardiotoxicity of tricyclic antidepressants in primary cultures of rat myocardial cells. J Toxicology Environ Health 14:137–143

    Article  CAS  Google Scholar 

  2. Cleophas TJ (1997) Depression and myocardial infarction. Implications for medical prognosis and options for treatment. Drugs-Aging 11 (2): 111–118

    Article  PubMed  CAS  Google Scholar 

  3. Feighner JP (1995) Cardiovascular safety in depressed patients: focus on venlafaxine. J Clin Psychiatry 56: 574–579

    PubMed  CAS  Google Scholar 

  4. Glassman AH (1998) Cardiovascular effects of antidepressant drugs: updated. J Clin Psychiatry 59 (Suppl 15): 13–18

    PubMed  CAS  Google Scholar 

  5. Glassman AH, Preud’homme XA (1993) Review of the cardiovascular effects of heterocyclic antidepressants. J Clin Psychiatry 54(Suppl): 16–22

    PubMed  Google Scholar 

  6. Grunder G, Wetzel H, Schlosser R, Benkert O (1996) Subchronic antidepressant treament with venlafaxine or imipramine andeffects on blood pressure and heart rate: assessment by automatic 24-hour monitoring. Pharmacopsychiatry 29: 72–78

    Article  PubMed  CAS  Google Scholar 

  7. Hewer W, Rost W, Gattaz WF (1995) Cardiovascular effects of fluvoxamine and maprotiline in depressed patients. Eur Arch Psychiatry Clin Neurosci 246:1–6

    Article  PubMed  CAS  Google Scholar 

  8. Moir DC (1973) Tricyclic antidepressants and cardiac disease. Am Heart J 86: 841–842

    Article  PubMed  CAS  Google Scholar 

  9. Moir DC, Crooks J, Sawyer P, Turnbull MJ, Weir RD (1972) Proceedings: Cardiotoxicity of tricyclic antidepressants. Br J Pharmacol 44:371–372

    Google Scholar 

  10. Obrador D, Ballester M, Carrio I, Moya C, Bosch I, Marti V, Berna 1, Estroch M, Udina C, Marrugat J, Auge J, Carreras F, Pons-Llado G, Caralps J (1994) Presence, evolving changes and prognostic implications of myocardial damage detected in idiopathic and alcoholic dilated cardiomyopathy. Circulation 89: 2054–2061

    PubMed  CAS  Google Scholar 

  11. Pratt LA, Ford DE, Crum RM, Atmenian HK, Gallo JJ, Eaton WW et al (1996) Depression, psychotrophic medication and risk of myocardial infarction. Prospektive data from the Baltimore ECA follow-up. Circulation 94:3123–3129

    PubMed  CAS  Google Scholar 

  12. Sheline YI, Freedland KE, Carney RM (1997) How safe are serotonin reuptake inhibitors for depression in patients with coronary heart disease? Am J Med 102(1): 54–59

    Article  PubMed  CAS  Google Scholar 

  13. Svensson TH, Usdion T (1978) Feedback inhibition of brain noradrenaline neurons by tricyclic antidepressants: alpha- receptor mediation. Science 202:1089–1091

    Article  PubMed  CAS  Google Scholar 

  14. Taylor DJ, Braithwaite RA (1978) Cardiac effects of tricyclic antidepressant medication. A preliminary study of nortriptyline. Br Heart J 40:1005–1009

    Article  PubMed  CAS  Google Scholar 

  15. Veith RC, Raskind MA, Caldwell JH, Barnes RF, Gumbrecht G, Ritchie JL (1982) Cardiovascular effects of tricyclic antidepressants in depressed patients with chronic heart disease. N Engl J Med 306:954–959

    Article  PubMed  CAS  Google Scholar 

2.5 Auswirkung von Digitalis auf den Herzrhythmus

  1. Borgeat A, Petropoulos P, Cavin R et al (1991) Prevention of arrhythmias after noncardiac thoracic operations: Flecainide versus digoxin. Ann Thorac Surg 51: 964–968

    Article  PubMed  CAS  Google Scholar 

  2. Cowan JC, Gardiner P, Reid DS, et al. (1986) A comparison of amiodarone and digoxin in the treatment of atrial fibrillation complicating suspected acute myocardial infarction. J. Cardiovasc Pharmacol 8: 252–256

    Article  PubMed  CAS  Google Scholar 

  3. Falk RH (1992) Proarrhythmia in patients treated for atrial fibrillation or flutter. Ann Intern Med 117:141–150

    PubMed  CAS  Google Scholar 

  4. Falk RH, Knowlton AA, Bernard SA et al (1987) Digoxin for converting recent-onset atrial fibrillation to sinus rhythm. A randomized, double-blinded trial. Ann Intern Med 106: 503–506

    PubMed  CAS  Google Scholar 

  5. Fisch C (1990) Electrocardiography of arrythmias. Lea & Febiger, Philadelphia London

    Google Scholar 

  6. Grande P, Sonne B, Pederson A (1986) A controlled study of digoxin and quinidine in patients DC reverted from atrial fibrillation to sinus rhythm. Circulation 74 (Suppl): II-402

    Google Scholar 

  7. Hjelms E (1992) Procainamide conversion of acute atrial fibrillation after open-heart surgery compared with digoxin treatment. Scand J Thorac Cardiovasc Surg 26:193–196

    PubMed  CAS  Google Scholar 

  8. Meijler FL (1985) An „account“of digitalis and atrial fibrillation. J Am Coll Cardiol (Suppl): 60A-68A

    Google Scholar 

  9. Prystowsky EN, Benson W, Fuster V et al (1996) Management of patients with atrial fibrillation. A statement for healthcare professionals from the subcommittee on Electrocardiography and Electrophysiology, American Heart Association. Circulation 93:1262–1277

    PubMed  CAS  Google Scholar 

  10. Steinbeck G, Doliwa R, Bach P (1988) Therapie des paroxysmalen Vorhoffflimmerns. Dtsch Med Wochenschr 113:1867–1871

    Article  PubMed  CAS  Google Scholar 

  11. Rawles JM, Metcalfe MJ, Jennings K (1990) Time of occurrence, duration, and ventricular rate of paroxysmal atrial fibrillation: The effect of digoxin. Br Heart J 63: 225–227

    Article  PubMed  CAS  Google Scholar 

2.6 Primärprävention durch Lipidsenkung

  1. Assmann G, Cullen P (1995) Nationale kardiovaskuläre Initiative: Erkennung und Behandlung von Fettstoffwechselstörungen. Dtsch Ärztebl, Beilage z. Heft 51/52

    Google Scholar 

  2. Cremer P, Nagel D (1992) Diagnostische Strategien zur Beurteilung von Fettstoffwechselstörungen und zur therapeutischen Zielsetzung. Internist 33:32–37

    PubMed  CAS  Google Scholar 

  3. Downs JR et al (1998) Primary Prevention of Acute Coronary Events with Lovastatin in men and women with average cholesterol levels. Results of AFCAPS/Tex CAPS. JAMA 279:1615–1622

    Article  PubMed  CAS  Google Scholar 

  4. Empfehlungen zur Therapie von Fettstoffwechselstörungen, Arzneimittelverordnung in der Praxis (AVP)-Sonderheft 2. Aufig. 1999, Arzneimittelkommission der Deutschen Ärzteschaft.

    Google Scholar 

  5. Frick MH et al (1987) Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia: safety of treatment, changes in risk factors, and incidence of coronary heart disease. N Engl J Med 317:1237–1245

    Article  PubMed  CAS  Google Scholar 

  6. Klose G, Schwabe U (1999) Lipidsenkende Mittel in: Arznei- verordnungsreport 99. Springer Verlag Berlin Heidelberg New York

    Google Scholar 

  7. Klose G (1996) Sieg der Primärprävention - oder? Fortschr Med 114:231–232

    PubMed  CAS  Google Scholar 

  8. Shepherd J, et al (1995) for the West of Scotland Coronary Prevention Study Group Prevention of coronary heart disease with Pravastatin in men with hypercholesterolemia. N Engl J Med 333:1301–1307

    Article  PubMed  CAS  Google Scholar 

  9. The Lipid Research Clinics Coronary Primary Prevention Trial results (1984) II. The relationship of reduction in incidence of coronary heart disease to cholesterol lowering. J Am Med Assoc 251:365–374

    Article  Google Scholar 

2.7 Thrombolyse bei Dialysepatienten

  1. Ryan TJ, Anderson JL, Antman EM, Braniff BA, Brooks NH, Califf RM, Hillis LD, Hiratzka LF, Rapaport E, Riegel BJ, Russell RO, Smith EE III, Weaver WD (1996) ACC/AHA guidelines for the manage ment of patients with acute myocardial infarction: a report of the American College of Cardiologie/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction). J Am Coll Cardiol 28:1328–1428

    Article  PubMed  CAS  Google Scholar 

  2. Hirsh J, Hoak J (1996) AHA Medical/Scientific Statement: Mana gement of deep vein thrombosis and pulmonary embolism. Circulation 93: 2212–2245

    PubMed  CAS  Google Scholar 

  3. Diehm C, Stammler F, Amendt K (1997) Die tiefe Beinvenen thrombose. Dt Ärzteblatt 94: A301–311

    Google Scholar 

2.8 Reinsult bei Vorhofflimmern

  1. EAFT (European Atrial Fibrillation Trial) study group (1993) Secondary prevention in non-rheumatic atrial fibrillation alter transient ischaemic attack or minor stroke. Lancet 342:1255–1262

    Google Scholar 

  2. Petersen P, Boysen G, Godtfredsen J, Andersen ED, Andersen B (1989) Placebo controlled, randomised trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation: The Copenhagen AFASAK study. Lancet 1:175–179

    Article  PubMed  CAS  Google Scholar 

  3. Stroke prevention in atrial fibrillation investigators (1995) Risk factors for thromboembolism during aspirin therapy in patients with atrial fibrillation: the stroke prevention in atrial fibrillation study. J Stroke Cerebrovasc Dis 5:147–157

    Article  Google Scholar 

  4. Stroke prevention in atrial fibrillation investigators (1994) Warfarin vs. aspirin for prevention of thromboembolism in atrial fibrillation: stroke prevention in atrialfibrillation 11 study. Lancet 343: 687–691

    Google Scholar 

  5. Wolf PA, Dawber TR, Thomas HE, Kannel WB (1978) Epidemiologic assessment of chronic atrial fibrillation and risk of stroke: the framingham study. Neurology 28: 973–977

    PubMed  CAS  Google Scholar 

2.9 Thromboseprophylaxe bei Insultpatienten

  1. Antiplatelet Trialists’ Collaboration (1994) Collaborative overview of randomised trials of antiplatelet therapy-III. Reduction in venous thrombosis and pulmonary embolism by antiplatelet prophylaxis among surgical and medical patients. BMJ 308: 235–246

    Google Scholar 

  2. Harenberg J, Roebruck P, Stehle G, Habscheid W, Biegholdt M, Heene DL, and the HESIM-Group (1992) Heparin study in internal medicine (HESIM): design and preliminary results. Thromb Res 68:33–43

    Article  PubMed  CAS  Google Scholar 

  3. International Consensus Statement (1995) Prevention of venous thromboembolism. In: Nikolaides AN, Bergqvist D, Hall R (eds) World congress af the international union of angiology, London

    Google Scholar 

  4. Kay R, Wong SK, Yu YL, Chan YW, Tsoi TH, Ahuja AT, Chan FL, Fong KY, Law CB, Wong A, Woo J (1995) Low-molecular-weight heparin for the treatment of acute ischemic stroke. N Engl J Med 333:1588–1593

    Article  PubMed  CAS  Google Scholar 

  5. Miller VT, Hart RG (1988) Heparin anticoagulation in acute brain ischemia. Stroke 19: 403–406

    Article  PubMed  CAS  Google Scholar 

  6. Partsch H (1996) Diagnose und Therapie der tiefen Venen thrombose. VASA [Suppl] 46:13

    Google Scholar 

  7. Turpie AG, Gent M, Cote R, Levine MN, Ginsberg JS, Powers PJ, Leclerc J, Geerts W, Jay R, Neemeh J (1992) A low-molecular-weight heparinoid compared with unfractionated heparin in the prevention of deep vein thrombosis in patients with acute ischemic stroke. A randomized, double-blind study. Ann Intern Med 117:353–357

    PubMed  CAS  Google Scholar 

2.10 Alternativen zu ASS?

  1. Arcan JC, Blanchard J, Boissel JP, Destors JM, Panak E (1988) Multicenter double-blind study of ticlopidine in the treatment of intermittent claudication and the prevention of its complications. Angiology 39: 802–811

    Article  PubMed  CAS  Google Scholar 

  2. Balsano F, Coccheri S, Libretti A, Nenci GG, Catalano M, Fortunato G, Grasselli S, Violi F, Hellemans H, Vanhobe PH (1989) Ticlopidine in the treatment of intermittent claudications: A 21-months double blind trial. J Lab Clin Med 114: 84–91

    PubMed  CAS  Google Scholar 

  3. Balsano F, Rizzon P, Violi F, Scrutinio D, Cimminiello C, Aguglia F, Pasotti C, Rudelli G (1990) Antiplatelet treatment with ticlopidine in unstable angina: A controlled multicenter clinical trial. Circulation 82:17–26

    Article  PubMed  CAS  Google Scholar 

  4. Barnathan ES, Schwartz JS, Taylor L, Laskey WK, Kleaveland JP, Kussmaul WG, Hirshfeld JW (1987) Aspirin and dipyridamole in the prevention of acute coronary thrombosis complicating coronary angioplasty. Circulation 76:125–134

    Article  PubMed  CAS  Google Scholar 

  5. CAPRIE - Steering Committee (1996) A randomised, blinded, trial of clopiidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet 348:1329–1339

    Article  Google Scholar 

  6. Collaborative overview of randomised trials of antiplatelet therapy -1: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. (1994) Br Med J 308: 81–106

    Google Scholar 

  7. DeCatarina R, Sicaria R, Bernini W, Lazzerini G, Strata GB, Gianessi D (1991) Benefit/Risk profile of combined antiplatelet therapy with ticlopidine and aspirin. Thrombos Hemostas 65: 504–510

    Google Scholar 

  8. EAFT-Study Group (1993) European Atrial Fibrillation Trial: Secondary prevention of vascular events in patients with nonrheumatic atrial fibrillation and recent transient ischaemic attack or minor ischaemic stroke. Lancet 342:1255–1262

    Google Scholar 

  9. Elwood PC, Sweetnam PM (1979) Aspirin and secondary mortality after myocardial infarction. Lancet 2:1313–1315

    Article  PubMed  CAS  Google Scholar 

  10. Falk EP, Shah K, Fuster V (1995) Coronary plaque disruption. Circulation 92: 657–671

    PubMed  CAS  Google Scholar 

  11. Fitzgerald GA, Oates JA, Hawiger J, Maas RL, Roberts LJ 2d, Lawson JA, Brash AR (1983) Endogenous biosynthesis of prostaglandin and thromboxane and platelet function during chronic admin istration of aspirin in man. J Clin Invest 71: 678–688

    Article  Google Scholar 

  12. Gent M, Blakeley JA, Easton JD, Ellis DJ, Hachinski VC, Harbison W, Panak E, Roberts RS, Sicuralla J, Turpie AGG, and the CATS Group (1989) The Canadian American Ticlopidine Study (CATS) in thromboembolic stroke. Lancet 2:1215–1220

    Article  Google Scholar 

  13. Graham DY, Smith JL, Dobbs SM (1983) Gastric adaptation occurs with aspirin administration in man. Dig Dis Sci 28:1–6

    Article  PubMed  CAS  Google Scholar 

  14. Hass WK, Easton JD, Adams HP, Pryse-Phillips W, Molony BA, Sharon A, Kamm B (1989) A randomized trial comparing ticlopidine hydrochloride with aspirin for the prevention of stroke in high-risk patients. N Engl J Med 321: 501–507

    Article  PubMed  CAS  Google Scholar 

  15. Hirsh J, Dalen JE, Fuster V, Harker LB, Salzman EW (1992) Aspirin and other platelet-active drugs. Chest 192 [Suppl 4]: 327S-336S

    Google Scholar 

  16. ISIS - 2 Collaborative Group (1988) Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17187 cases of suspected acute myocardial infarction: ISIS-2. Lancet 318:349–360

    Google Scholar 

  17. Janzon LD, Berquist D, Boberg J, Boberg M, Eriksson L, Lindgàrde F, Persson G (1990) Prevention of myocardial infarction and stroke in patients with intermittent claudication: Effects of Ticlopidine. J Int Med Res 227:301–308

    Article  CAS  Google Scholar 

  18. Kannel KB, Abbott RD, Savage DD, McNamara PM (1982) Epidemiologic features of chronic atrial fibrillation. N Engl J Med 306:1018–1022

    Article  PubMed  CAS  Google Scholar 

  19. Kyrle PA, Eichler HG, Jager U, Lechner K (1987) Inhibition of prostaglandin and thromboxane A2 generation by low-dose aspirin at the site of plug formation in man in vivo. Circulation 75:1025–1029

    Article  PubMed  CAS  Google Scholar 

  20. Limet R, David JL, Magotteaux P, Larock MP, Rigo P (1987) Prevention of aorto-coronary bypass graft occlusion: Beneficial effect of triclopidine on early and late patency rate of venous coronary bypass grafts: A double-blind study. J Thorac Cardiovasc Surg 94: 773–783

    PubMed  CAS  Google Scholar 

  21. O’Laughlin JC, Hoftiezer JW, Ivey KJ (1981) Effect of aspirin on the human stzomach in normals: Endoscopic comparison of damage produced one hour, 24 hours, and 2 weeks after administrations. Scand J Gastroenterol 67 [Suppl]: 211–214

    Google Scholar 

  22. Ono K, Kurohara K, Yoshihara M, Shimamoto Y, Yamaguchi M (1991) Agranulocytosis caused by ticlopidine and its mechanism. Am J Hematol 37: 239–242

    Article  PubMed  CAS  Google Scholar 

  23. Peto R, Gray R, Collins K, Wheatley K, Hennekens C, Jamrozik K, Warlow C, Hafner E, Thompson E, Norton S, Gilliland J, Doll R (1988) Randomised trial of prophylactic daily aspirin in British male doctors. Br Med J 296:313–316

    Article  CAS  Google Scholar 

  24. Ridker PM, Manson JE, Gaziano JM, Buring JE, Hennekens CH (1991) Low-dose aspirin therapy for chronic stable angina. Ann Intern Med 114: 835–839

    PubMed  CAS  Google Scholar 

  25. Ruggeri M, Castaman G, Rodeghiero F (1993) Is ticlopidine a safe alternative to aspirin for management of myeloproliferative disorders? Haematological 78 [Suppl 2]: 18–21

    CAS  Google Scholar 

  26. Savi P, Laplace MC, Maffrand JP, Herbert JM (1994) Binding of [3H]-2-methylthio ADP to rat platelets: Effect of clopidogrel and triclopidine. J Pharmacol Exp Ther 269: 772–777

    PubMed  CAS  Google Scholar 

  27. Schömig A, Neumann FJ, Kastrati A, Schuhlen H, Blasini R, Hadamitzky M, Walter H, Zitzmann Roth EM, Richardt G, Alt E, Schmitt C, Ulm K (1996) A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents. N Engl J Med 334:1084–1089

    Article  PubMed  Google Scholar 

  28. Schwartz L, Bouroussa MG, Lesperance J, Aldridge HE, Kazim F, Salvatori VA, Henderson M, Bonan R, David PR (1988) Aspirin and dipyridamole in the prevention of restenosis after percutaneous transluminal coronary angioplasty. N Engl J Med 318:1714–1719

    Article  PubMed  CAS  Google Scholar 

  29. Scrutinio D, Lagioia R, Rizzon P (1991) Ticlopidine treatment for patients with unstable angina at rest. A further analysis of the study of ticlopidine in unstable angina. Studio della Ticlopidina nell’ Angina Instabile Group. Eur Heart J12 [Suppl G]: 27–29

    Google Scholar 

  30. Shear NH, Appel C (1995) Prevention of ischemic stroke (Letter). N Engl J Med 333: 460

    PubMed  CAS  Google Scholar 

  31. Smits Steering Committee of the Physicians’ Health Study Research Group (1988) Preliminary Report: Findings from the aspirin component of the ongoing Physicians’ Health Study. N Engl J Med 318: 262–264

    Article  Google Scholar 

  32. The Boston Area Anticopagulation Trial for Atrial Fibrillation Investigators. The effect of low-dose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation. (1990) N Engl J Med 323:1505–1511

    Article  Google Scholar 

  33. The Dutch TIA Trial Study Group (1991) The effects of 30 mg versus 300 mg acetylsalicylic acid, and of 50 mg atenolol versus placebo on mortality, stroke and myocardial infarction after TIA or minor stroke. N Engl J Med 325:1261–1266

    Article  Google Scholar 

  34. Van der Wal AC, Becker AE, Van der Loos CM, Das PK (1994) Site of intimal rupture or erosion on thrombosed coronary artery plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology. Circulation 89:3 6–44

    Google Scholar 

  35. Weksler BB, Pett SB, Alonso D, Richter RC, Stelzer P, Subramanian V, Tack-Goldman K, Gay-Wa Jr (1983) Differential inhibition by aspirin of vascular and platelet prostaglandin synthesis in atherosclerotic patients. N Engl J Med 308: 800–805

    Article  PubMed  CAS  Google Scholar 

2.11 Antithrombozytäre Therapie rezidivierender TIA’s

  1. Antiplatelet Trialists’ Collaboration [1994) Collaborative overview of randomised trials of antiplatelet therapy - I: Prevention of death, myocardial infarction and stroke by prolonged antiplatelet therapy in various categories of patients. BMJ 308: 81–106

    Google Scholar 

  2. Bousser MG, Eschwege E, Haguenau M, Lefaucconnier JM, Thibult N, Touboul D, Touboul P (1983) “AICLA”: Controlled trial of aspirin and dipyridamole in the secondary prevention of atherothrombotic cerebral ischemia. Stroke 14:5–14

    Google Scholar 

  3. CAPRIE-Steering Commitee (1996) CAPRIE-Study: A randomized, blinded trial of clopidogrel versus aspirin in patients at risk of ischaemic events. Lancet 348:1329–1339

    Article  Google Scholar 

  4. Hall P, Nakamura S, Maiello L, Itoh A, Blengino S, Martini G, Ferraro M, Colombo A (1996) Randomized comparison of combined ticlopidine and aspirin therapy versus aspirin therapy alone after successful intravascular ultrasound-guided stent implantation. Circulation 93: 215–222

    PubMed  CAS  Google Scholar 

  5. Halperin JL, Hart RG (1988) Atrial fibrillation and stroke: New ideas and persistent dilemmas. Stroke 19: 937–941

    Article  PubMed  CAS  Google Scholar 

  6. Hass WK, Easton JD, Adams HP, Pryse-Phillips W, Molony BA, Anderson S (1989) A randomised trial comparing ticlopidine hydrochloride with aspirin for the prevention of stroke in high- risk patients. N Engl J Med 321: 501–507

    Article  PubMed  CAS  Google Scholar 

  7. Sherman DG, Dyken ML, Fisher M, Gent M, Harrison MJG, Hart RG (1992) Antithrombotic therapy for cerebrovascular disorders. Chest 102 [Suppl]: 529–539

    Article  Google Scholar 

  8. Sherman DG, Hart RG (1992) Stroke and transient ischemic attack: Thromboembolism and antithrombotic therapy. In: Fuster V, Verstraete M (eds) Thrombosis in cardiovascular disorders. WB Saunders, Philadelphia S 409–422

    Google Scholar 

  9. Stroke Prevention in Atrial Fibrillation Investigators (1991) Stroke Prevention in Atrial Fibrillation Study-Final Results. Circulation 84:527–539

    Google Scholar 

  10. The Dutch TIA Trial Study Group (1991) A comparison of two doses of aspirin (30 mg versus 283 mg a day) in patients after a transient ischemic attack or minor ischemic stroke. N Engl J Med 325:1261–1266

    Article  Google Scholar 

  11. The SALT Collaborative Group (1991) Swedish Aspirin Low Dose trial (SALT) of 75 mg of aspirin as secondary prophylaxis after cerebrovascular ischemic events. Lancet 338:1345–1349

    Article  Google Scholar 

  12. The Veterans Affairs Stroke Prevention in nonrheumatic atrial fibrillation investigators. (1992) Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation. N Engl J Med 327:1406–1412

    Article  Google Scholar 

  13. UK-TIA Study Group (1991) The United Kingdom Transient Ischemic Attack (UK-TIA) aspirin trial. J Neurosurg Psychiatry 54:1044–1054

    Article  Google Scholar 

  14. Weinberger J, Ramos L, Ambrose JA, Fuster V (1988) Morphologic and dynamic changes of atherosclerotic plaque at the carotid artery bifurcation. Sequential imaging by real time B-mode ultrasonography. J Am Coll Cardiol 12:1515–1521

    Article  PubMed  CAS  Google Scholar 

2.12 Heparinprophylaxe

  1. Guex II (1996) Thrombotic complications of varicose veins. A literatur review of the role of superficial venous thrombosis. Dermatologie Surgery 22:378–382

    Article  CAS  Google Scholar 

  2. Kakkar W, Cohen AT, Edmonson RA, et al. (1993) Low molecular weight versus standard heparin for prevention of venous thromboembolism after major abdominal surgery. Lancet 341: 259–265

    Article  PubMed  CAS  Google Scholar 

  3. Kock HJ, Schmitt-Neuerburg KP, Hanke J, et al. (1994) Durchfüh rung der ambulanten Thromboseprophylaxe mit nieder molekularem Heparin bei Gipsimmobilisation der unteren Ex tremität. Unfallchirurgie 20:319–328

    Article  PubMed  CAS  Google Scholar 

  4. Kujath P, Spannagel H, Habscheid W, et al. (1992) Thromboseprophylaxe bei ambulanten Patienten mit Verletzungen der unte ren Extremität. Dtsch Med Wochenschr 117: 6–10Nurmohamed MT, Rosendaal FR, Buller HR, et al. (1992) Low molecular weight heparin versus standard heparin in general and orthopaedic surgery: a meta analysis. Lancet 340:152–156

    Article  Google Scholar 

  5. Schmitt-Neuerburg KP (1990) Empfehlungen der Deutschen Ge sellschaft für Unfallheilkunde e.V. zur Thromboseprophylaxe bei ambulanten Patienten. Ergebnisse eines Expertengespräches am 13.01.90 in Essen. Unfallchirurg 93:358

    Google Scholar 

2.13 Kompressionsbehandlung bei Beinvenenthrombose

  1. Brakkee AJM, Kuiper JP (1988) The influence of compressive stockings on the hemodynamics in the lower extremities. Phlebology 3:147–153

    Google Scholar 

  2. Braun-Falco O, Plewig G, Wolff HH, Winkelmann RK (1991) Dermatology. Springer, Berlin Heidelberg New York, S 641–642

    Google Scholar 

  3. Coleridge Smith P, Sarin S, Hasty J et al. (1990) Sequential gradient pneumatic compression enhances venous ulcer healing: a randomized trial. Surgery 108: 871–875

    Google Scholar 

  4. Dalman RL, Zarins CK, Harris EJ (1996) Vascular ulcers. In: Loscalzo J, Creager MA, Dzau VJ (eds) Vascular medicine. A textbook of vascular biology and diseases. Little, Brown and Company, Boston New York Toronto London S 1173–1186

    Google Scholar 

  5. Franzeck UK, Schalch I, Jäger KA, Schneider E, Grimm J, Bollinger A (1996) Prospective 12-year follow-up study of clinical and hemodynamic sequelae after deep vein thrombosis in low-risk patients (Zürich study). Circulation 93: 74–79

    PubMed  CAS  Google Scholar 

  6. Hach W (1989) Evaluation and management of post-thrombotic syndrome. Herz 14: 287–297

    PubMed  CAS  Google Scholar 

  7. Holford CP (1976) The effect of graduated static compression on isotopically diagnosed deep vein thrombosis of the leg. Brit J Surg 63:157

    PubMed  CAS  Google Scholar 

  8. Johnson G, Kupper C, Farrar DJ, Swallow RT (1982) Graded compression stockings. Arch Surg 117: 69–72

    PubMed  Google Scholar 

  9. Lentner A, Wienert V (1994) Schäden durch Antithrombose- strümpfe. Dtsch Med Wochenschr 119:18031o. Leyhe A (1993) Ist eine Kompressions-Therapie bei akuter tiefer Beinvenenthrombose zur Förderung des venösen Flusses immer indiziert (Basismaßnahme)? Internist 34:188–189

    Google Scholar 

  10. Martin M (1994) Grundzüge der klinischen Phlebologie. Huber, Bern Göttingen Toronto Seattle, S 64–71

    Google Scholar 

  11. Mayberry JC, Moneta GL, De Frang RD et al. (1991) The influence of elastic compression stockings on deep venous hemodynamics. J Vase Surg 13: 91–99

    Article  CAS  Google Scholar 

  12. Mühe E (1982) Ein neuer Weg in der Thromboseprophylaxe. Intermittierende sequentielle Beinkompression mit hohen Drükken. Dtsch Med Wochenschr 107:1092–1095

    Article  PubMed  Google Scholar 

  13. Partsch H (1982) Treatment of chronic venous insufficiency. In: Foley T (ed) Advances in the management of cardiovascular disease, vol 3. Year Book Medical Publishers, Chicago London, S 333–347

    Google Scholar 

  14. Partsch H (1984) Besserung der venösen Pumpleistung bei chronischer Veneninsuffizienz durch Kompression in Abhängigkeit von Andruck und Material. VAS A13,52

    Google Scholar 

  15. Partsch H (1989) Phlebologiekurs. 5teilige Fortbildungsreihe der „Arbeitsgemeinschaft Phlebologie der Österreichischen Gesellschaft für Dermatologie und Venerologie“, S 250–253,259–262,359–361

    Google Scholar 

  16. Partsch H (1991) Compression therapy of the legs: A review. J Dermatol Surg Oncol 17:799–808

    PubMed  CAS  Google Scholar 

  17. Prandoni P, Lensing AWA, Cogo A et al. (1996) The long-term clinical course of acute deep venous thrombosis. Ann Intern Med 125:1–7

    PubMed  CAS  Google Scholar 

  18. Scurr JH, Ibrahin S, Faber RG, Le Quesne LP (1977) The efficacy of graduated compression stockings in the prevention of deep vein thrombosis. Br J Surg 64:371–373

    Article  PubMed  CAS  Google Scholar 

  19. Wienert V, Altenkämper H, Berg D, Fuckner M, Jüner M, Rabe E, Stemmer R (1998) Leitlinien zum medizinischen Kompressionsstrumpf (MKS). Phlebologie 27: 89–91

    Google Scholar 

2.14 Orale Antikoagulation nach Phlebothrombose

  1. Bruhn HD, Zurborn KH (1993) Kontrolle des individuellen antikoagulatorischen Effekts einer Behandlung mit oralen CumarinDerivaten in niedriger Intensität durch Messung des Prothrombinfragments F 1+2. Hämostaseologie 13:167–171

    Google Scholar 

  2. Hull R, Hirsh J et al. (1982) Different intensities of oral anticoagulant therapy in the treatment of proximal-vein thrombosis. N Engl J Med 307:1676–1681

    Article  PubMed  CAS  Google Scholar 

  3. Hylek EM, Singer DE (1994) Risk factors for intracranial hemor rhage in outpatients. Ann Intern Med 120: 897–902

    PubMed  CAS  Google Scholar 

  4. Kohl P, Niedermaier J, Hiller E (1992) Therapie mit Cumarinderivaten. Arzneimitteltherapie 10:107–110

    Google Scholar 

  5. Lechner K, Gaiger A, Fritz A, Kyrie P, Eichinger S, Pabinger I (1992) Probleme der Langzeitantikoagulanzientherapie. AMA 19: 21–24

    CAS  Google Scholar 

  6. Levine MN, Raskob G, Hirsh J (1986) Hemorrhagic Complications of Long-term Anticoagulant Therapy. Chest 89,16S-25S

    PubMed  CAS  Google Scholar 

  7. Loeliger EA (1992) Therapeutic target values in oral anticoagulation - Justification of Dutch policy and a warning against the so called moderate-intensity regimens. Ann Hematol 64: 60–65

    Article  PubMed  CAS  Google Scholar 

2.15 Stent-Implantation bei Aortenaneurysma

  1. Dake MD, Miller DC, Semba CP, Mitchell RS, Walker PJ, Liddell RP (1994) Transluminal placement of endovascular stent-grafts for the treatment of descending thoracic aortic aneurysms. N Engl J Med 331:1729

    Article  PubMed  CAS  Google Scholar 

  2. Blum U, Voshage G, Lammer J, Beyersdorf F, Tollner D, Kretschmer G, Spillner G, Polterauer P, Nagel G, Holzenbein T, Thurnher S, Langer M (1997) Endoluminal stent-grafts for infrarenal abdo minal aortic aneurysms. N Engl J Med 336:13

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Universität Leipzig, Herzzentrum, Kardiologie, Russenstr. 19, D-04289, Leipzig, Germany

    Priv.-Doz. Dr. H. Kottkamp & Dr. G. Hindricks

  2. Klinik III für Innere Medizin der Universität zu Köln, Joseph-Stelzmann-Straße 9, D-50924, Köln, Germany

    Prof. Dr. M. Böhm

  3. Abteilung Kardiologie, Angiologie und Pulmologie der, Medizinischen Universitätsklinik, Bergheimer-Straße 58, D-69115, Heidelberg, Germany

    Dr. M. Braun & Prof. Dr. R. H. Strasser

  4. Medizinische Klinik und Poliklinik, Innere Medizin C, Westfälische Wilhelms-Universität, Albert-Schweitzer-Str. 39, D-48129, Münster, Germany

    Dr. W. Haverkamp & Prof. Dr. G. Breithardt

  5. Medizinische Klinik, Zentralkrankenhaus Links der Weser, Senator-Weßling-Straße 1, D-28277, Bremen, Germany

    Prof. Dr. G. Klose

  6. Medizinische Klinik II, Klinikum Kreis Herford, Schwarzenmoorstraße 70, D-32049, Herford, Germany

    Dr. W. Schnieder & Prof. Dr. U. Schmitz-Huebner

  7. Angiologische Abteilung, Städtisches Krankenhaus München Schwabing, Kölner Platz 1, D-80804, München, Germany

    Dr. H. Stiegler

  8. Abteilung Kardiologie und Pulmologie der, Georg-August-Universität, Robert-Koch-Straße 40, D-37075, Göttingen, Germany

    Prof. Dr. A. B. Buchwald

  9. Medizinische Universitäts-Klinik und Poliklinik II, Sigmund-Freud-Straße 25, D-53105, Bonn, Germany

    Priv.-Doz. Dr. L. Pizzulli & Prof. Dr. B. Lüderitz

  10. Medizinische Klinik, Hämatologie/Onkologie, Evangelisches Krankenhaus Hamm, Werler Straße 110, D-59063, Hamm, Germany

    Prof. Dr. L. Balleisen

  11. Medizinische Klinik I, Universitätsklinikum, Joseph-Stelzmann-Straße 9, D-50931, Köln, Germany

    Dr. D. Söhngen

  12. Klinik für Hämatologie, Onkologie und klinische Immunologie der, Heinrich Heine Universität, Moorenstraße 5, D-40225, Düsseldorf, Germany

    Prof. Dr. W. Schneider

  13. Strandklinik Boltenhagen, Ostseeallee 103, D-23945, Ostseebad Boltenhagen, Germany

    Dr. G. Schwieder

  14. Klinik für Thorax-, Herz- und Gefäßchirurgie, Westfälische Wilhelms-Universität, Albert-Schweitzer-Straße 33, D-48149, Münster, Germany

    Dr. C. Schmid & Dr. H. H. Scheid

  15. Institut für Klinische Radiologie, Westfälische Wilhelms-Universität, Albert-Schweitzer-Straße 33, D-48149, Münster, Germany

    Dr. Th. Vestring

Authors
  1. Priv.-Doz. Dr. H. Kottkamp
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Dr. G. Hindricks
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Prof. Dr. M. Böhm
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Dr. M. Braun
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Prof. Dr. R. H. Strasser
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Dr. W. Haverkamp
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Prof. Dr. G. Breithardt
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Prof. Dr. G. Klose
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Dr. W. Schnieder
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Prof. Dr. U. Schmitz-Huebner
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Dr. H. Stiegler
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Prof. Dr. A. B. Buchwald
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. Priv.-Doz. Dr. L. Pizzulli
    View author publications

    You can also search for this author in PubMed Google Scholar

  14. Prof. Dr. B. Lüderitz
    View author publications

    You can also search for this author in PubMed Google Scholar

  15. Prof. Dr. L. Balleisen
    View author publications

    You can also search for this author in PubMed Google Scholar

  16. Dr. D. Söhngen
    View author publications

    You can also search for this author in PubMed Google Scholar

  17. Prof. Dr. W. Schneider
    View author publications

    You can also search for this author in PubMed Google Scholar

  18. Dr. G. Schwieder
    View author publications

    You can also search for this author in PubMed Google Scholar

  19. Dr. C. Schmid
    View author publications

    You can also search for this author in PubMed Google Scholar

  20. Dr. H. H. Scheid
    View author publications

    You can also search for this author in PubMed Google Scholar

  21. Dr. Th. Vestring
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. LMU München, Klinikum Großhadern Medizinische Klinik und Poliklinik III, Marchioninistraße 15, D-81377, München, Germany

    Wolfgang Hiddemann

Rights and permissions

Reprints and permissions

Copyright information

© 2000 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Kottkamp, H. et al. (2000). kardiologie und Angiologie. In: Hiddemann, W. (eds) Medizin im Brennpunkt. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-59730-5_2

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-59730-5_2

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-66864-0

  • Online ISBN: 978-3-642-59730-5

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation